alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › encephalopathy

encephalopathy

2 studies tagged encephalopathy, dated 2018-10-01 to 2025-11-17. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Diabetic encephalopathy: metabolic reprogramming as a potential driver of accelerated brain aging and cognitive decline 2025-11-17
  2. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy 2018-10-01

Studies

2 studies carry this tag.

Date range

2018 to 2025

Top journals

  • Brain : a journal of neurology 1
  • Frontiers in cell and developmental biology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Diabetic encephalopathy: metabolic reprogramming as a potential driver of accelerated brain aging and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Frontiers in cell and developmental biology 2025-11-17 Drug development

    Diabetic encephalopathy (DE) is a serious neurological complication of diabetes and is expressed as progressive decline in cognitive function, emotional disorders, and changes in brain structure.

  2. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Brain : a journal of neurology 2018-10-01 Drug development

    Exendin-4 is a drug used to treat type 2 diabetes mellitus that has also demonstrated neuroprotective properties, and is currently being tested in clinical trials for Alzheimer's and Parkinson's diseases.

All topic tags with their study counts